<DOC>
	<DOC>NCT00191178</DOC>
	<brief_summary>This study investigates the influence of two different insulin regimens, twice-daily insulin lispro low mix (LM) and once-daily insulin glargine, on perceived physical, mood, and cognitive symptoms as well as cognitive-motor task performance in patients with type 2 diabetes.</brief_summary>
	<brief_title>Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<mesh_term>Protamines</mesh_term>
	<criteria>Diagnosed as having type 2 diabetes mellitus, as defined by the World Health Organization Are being treated with metformin therapy alone, metformin therapy plus oncedaily insulin, or metformin plus one or more other oral antihyperglycemic agents at the time of study entry Female patients not breastfeeding and female patients of childbearing potential must test negative for pregnancy at time of study entry based on a urine pregnancy test and do not intend to become pregnant during the study and agree to use a reliable form of birth control during the study Hemoglobin A1c greater than or equal to 7.0% and less than or equal to 10% within 3 months prior to visit 1 Have given informed consent to participate in the study in accordance with local regulations Are investigator site personnel directly affiliated with the study, or are immediate family of investigator site personnel directly affiliated with the study. Have received treatment within the last 30 days with a drug that has not received regulatory approval for any indication at the time of study entry Have previously been diagnosed with clinical depression or have been treated with a central nervous system stimulant, antidepressant, antipsychotic, or anxiolytic agent within 30 days prior to study entry Have a known allergy to insulin lispro low mixture, insulin glargine, metformin hydrochloride, or excipients contained in these products Have known hypersensitivity or contraindication to metformin hydrochloride</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>